Skip to main content

Table 3 The early recurrence rate of patients with stage III gastric cancer

From: Development and validation of a prognostic nomogram for predicting early recurrence after curative resection of stage II/III gastric cancer

VariableAdjuvant chemotherapy ≥ 6 cyclesAdjuvant chemotherapy < 6 cyclesP
Tumor location   
 Lower third27/206 (13.1%)114/434 (26.3%)< 0.001
 Upper, middle third, or mixed28/132 (21.2%)114/280 (40.7%)< 0.001
Positive lymph node ratio   
 < 0.33515/172 (8.7%)74/371 (19.9%)0.001
 ≥ 0.33540/166 (24.1%)154/343 (44.9%)< 0.001
Lymphocyte count   
 ≥ 1.5 × 109/L31/214 (14.5%)124/439 (28.2%)< 0.001
 < 1.5 × 109/L24/124 (19.4%)104/275 (37.8%)< 0.001
Postoperative infection complications   
 No51/318 (16.0%)202/661 (30.6%)< 0.001
 Yes4/20 (20.0%)26/53 (49.1%)0.024